This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma/Biotech GTN Summit
November 18-20, 2024
W Philadelphia HotelPhiladelphia, PA

Eckart Beuttenmueller
Sr. Director Gross-To-Net Recovery & Innovation at Bayer Healthcare Pharmaceuticals, Inc.
Speaker

Profile

Eckart Beuttenmueller leads Gross-to-Net Recovery & Innovation at Bayer HealthCare Pharmaceuticals in Whippany, NJ. He is a recognized leader within U.S. Market Access Strategic Pricing & Reimbursement, tasked with identifying and capturing opportunities to improve and defend Gross-To-Net across Commercial and Government channels. His focus is primarily on customer and contract compliance, invoice validation, processing improvements and audits.

During his career, Eckart gained broad experience in the Healthcare industry via multiple Finance & Commercial roles in the U.S., Hungary and Germany. Through a Fulbright scholarship, Eckart obtained his M.Sc. at the University of Wisconsin and earned his Ph.D. in organic chemistry at the Max-Planck-Institute in Mülheim/Ruhr, Germany.

Bayer is a global enterprise with core competencies in the Life Science fields of Healthcare and Agriculture. Its vision of “Health for all and hunger for none” is focused on finding solutions to the world’s most pressing challenges in health and nutrition.

Agenda Sessions

  • GTN Operations: Cross-functional collaboration for process improvement

    9:45am